Literature DB >> 32067050

Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.

Erika Uusitupa1, Matti Waris2,3, Terho Heikkinen1,4.   

Abstract

BACKGROUND: There are scarce data on whether viral load affects the severity of respiratory syncytial virus (RSV) disease in outpatient children.
METHODS: We analyzed the association between viral load and disease severity among children who participated in a prospective cohort study of respiratory infections. The children were examined and nasal swabs for the detection of RSV were obtained during each respiratory illness. Quantification of RSV load was based on the cycle threshold (Ct) value. For the primary analysis, the children were divided into 2 groups: higher (Ct < 27) and lower viral load (Ct ≥ 27).
RESULTS: Among 201 episodes of RSV infection, children with higher viral load had significantly longer median durations of rhinitis (8 vs 6 days; P = .0008), cough (8 vs 6 days; P = .034), fever (2 vs 1 days; P = .018), and any symptom (10 vs 8 days; P = .024) than those with lower viral load. There were statistically significant negative correlations between the Ct values and durations of all measured symptoms.
CONCLUSIONS: Our findings support the concept that viral load drives the severity of RSV disease in children. Reducing the viral load by RSV antivirals might provide substantial benefits to outpatient children.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antiviral agents; children; disease severity; respiratory syncytial virus; viral load

Mesh:

Substances:

Year:  2020        PMID: 32067050     DOI: 10.1093/infdis/jiaa076

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life.

Authors:  Mari D Takashima; Keith Grimwood; Peter D Sly; Stephen B Lambert; Keith J Chappell; Daniel Watterson; Robert S Ware
Journal:  Eur J Pediatr       Date:  2021-02-25       Impact factor: 3.183

2.  Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection.

Authors:  Victor K Outlaw; Ross W Cheloha; Eric M Jurgens; Francesca T Bovier; Yun Zhu; Dale F Kreitler; Olivia Harder; Stefan Niewiesk; Matteo Porotto; Samuel H Gellman; Anne Moscona
Journal:  J Am Chem Soc       Date:  2021-04-07       Impact factor: 15.419

3.  Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children With Respiratory Syncytial Virus Infection.

Authors:  Helena Brenes-Chacon; Cristina Garcia-Mauriño; Melissa Moore-Clingenpeel; Sara Mertz; Fang Ye; Daniel M Cohen; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2021-02-01       Impact factor: 3.806

4.  Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.

Authors:  John DeVincenzo; Lindsey Cass; Alison Murray; Kathy Woodward; Elizabeth Meals; Matthew Coates; Leah Daly; Vicky Wheeler; Julie Mori; Charlie Brindley; Amanda Davis; Meabh McCurdy; Kazuhiro Ito; Bryan Murray; Pete Strong; Garth Rapeport
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

5.  Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study).

Authors:  Katrin Hartmann; Johannes G Liese; Daniel Kemmling; Christiane Prifert; Benedikt Weißbrich; Pushpike Thilakarathne; Joris Diels; Karin Weber; Andrea Streng
Journal:  J Infect Dis       Date:  2022-08-26       Impact factor: 7.759

6.  Detection of respiratory syncytial virus defective genomes in nasal secretions is associated with distinct clinical outcomes.

Authors:  Sébastien A Felt; Yan Sun; Agnieszka Jozwik; Allan Paras; Maximillian S Habibi; David Nickle; Larry Anderson; Emna Achouri; Kristen A Feemster; Ana María Cárdenas; Kedir N Turi; Meiping Chang; Tina V Hartert; Shaon Sengupta; Christopher Chiu; Carolina B López
Journal:  Nat Microbiol       Date:  2021-04-01       Impact factor: 30.964

7.  The effectiveness and safety of Tanreqing Injection combined with ganciclovir on the treatment of respiratory syncytial virus pneumonia in children: A protocol for systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei-Jun Zhu; Xuan Zhou; Juan Cao; Yu Shi
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.